Intelligence and cognitive function in children and adolescents with spinal muscular atrophy
- PMID: 11738354
- DOI: 10.1016/s0960-8966(01)00274-7
Intelligence and cognitive function in children and adolescents with spinal muscular atrophy
Abstract
Spinal muscular atrophy is a chronic disease characterised by loss of motor function. The aim of the study was to analyse cognitive functions in a large group of patients with spinal muscular atrophy. It was hypothesised that their intelligence is comparable to controls, but not above average as previously postulated. Ninety-six children and adolescents with spinal muscular atrophy I-III, aged 6.0-18.11 years, 45 non-affected siblings and 59 healthy, matched controls were examined with one- (CPM/SPM), as well as multi-dimensional intelligence tests (Kaufman-ABC; Wechsler tests). The mean IQ measured with the CPM/SPM tests was 109.6 for the spinal muscular atrophy group, 107.3 for the sibs and 104.1 for the healthy controls (no significant difference). In the older children and adolescents (SPM only) the mean IQ was significantly higher for the spinal muscular atrophy patients (109.6) than for the controls (95.4). The standard score in the 'mental processing composite' scale of the Kaufman-ABC was identical in the spinal muscular atrophy group and controls (103.8). The cognitive profile was relatively homogeneous. However, the older children and adolescents did have a significantly higher verbal IQ (113.8) than controls (104.6) in the Wechsler tests. There were no significant differences in any of the tests among different grades of severity (spinal muscular atrophy types I-III). It can be concluded that children and adolescents with spinal muscular atrophy have a general intelligence in the normal range. By adolescence, environmentally mediated aspects of intelligence are higher in patients with spinal muscular atrophy. It could be speculated that the development of cognitive skills and knowledge is a creative way to compensate the many restrictions due to their physical handicap.
Comment in
-
Cognitive function in children with spinal muscular atrophy.Neuromuscul Disord. 2002 Oct;12(7-8):693-4; author reply 694. doi: 10.1016/s0960-8966(02)00048-2. Neuromuscul Disord. 2002. PMID: 12207940 No abstract available.
Similar articles
-
Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA).Orphanet J Rare Dis. 2021 Jan 6;16(1):10. doi: 10.1186/s13023-020-01661-9. Orphanet J Rare Dis. 2021. PMID: 33407722 Free PMC article.
-
Intelligence May Moderate the Cognitive Profile of Patients with ASD.PLoS One. 2015 Oct 7;10(10):e0138698. doi: 10.1371/journal.pone.0138698. eCollection 2015. PLoS One. 2015. PMID: 26444877 Free PMC article.
-
Spatial cognition in young children with spinal muscular atrophy.Dev Neuropsychol. 2002;21(3):273-83. doi: 10.1207/S15326942DN2103_4. Dev Neuropsychol. 2002. PMID: 12233939
-
Clinical outcome measures in spinal muscular atrophy.J Child Neurol. 2009 Aug;24(8):968-78. doi: 10.1177/0883073809332702. Epub 2009 Jun 9. J Child Neurol. 2009. PMID: 19509409 Review.
-
Spinal muscular atrophy diagnostics.J Child Neurol. 2007 Aug;22(8):952-6. doi: 10.1177/0883073807305668. J Child Neurol. 2007. PMID: 17761649 Review.
Cited by
-
Motor and neurocognitive profiles of children with symptomatic spinal muscular atrophy type 1 with two copies of SMN2 before and after treatment: a longitudinal observational study.Front Neurol. 2024 Feb 21;15:1326528. doi: 10.3389/fneur.2024.1326528. eCollection 2024. Front Neurol. 2024. PMID: 38450080 Free PMC article.
-
Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment.Front Neurol. 2023 Nov 3;14:1226043. doi: 10.3389/fneur.2023.1226043. eCollection 2023. Front Neurol. 2023. PMID: 38020636 Free PMC article.
-
Impaired Neurodevelopment in Children with 5q-SMA - 2 Years After Newborn Screening.J Neuromuscul Dis. 2024;11(1):143-151. doi: 10.3233/JND-230136. J Neuromuscul Dis. 2024. PMID: 37927272 Free PMC article.
-
Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape.Int J Mol Sci. 2023 Sep 6;24(18):13743. doi: 10.3390/ijms241813743. Int J Mol Sci. 2023. PMID: 37762045 Free PMC article. Review.
-
Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy.Ther Adv Neurol Disord. 2023 Feb 20;16:17562864231154335. doi: 10.1177/17562864231154335. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36846472 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
